References
- Silvestris N, Cinieri S, La Torre I, . Role of gemcitabine in metastatic breast cancer patients: A short review. Breast 2008; 17:220–6.
- Ershler W. Capecitabine monotherapy: Safe and effective treatment for metastatic breast cancer. Oncologist 2006; 11:325–35.
- Sawada N, Fujimoto-Ouchi K, Ishikawa T, . Antitumor activity of combination therapy with capecitabine plus vinorelbin, and capecitabine plus gemcitabine in human tumor xenograft models. Proc Am Assoc Cancer Res 2002; 43:5388.(Abstract)
- Andres R, Mayordomo JI, Lara R, . Gemcitabine/capecitabine in patients with metastatic breast cancer pre-treated with anthracyclines and taxanes. Clin Breast Cancer 2005; 6:158–62.
- Benekli M, Yildis R, Uner A, . Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Oncology 2007; 72:308–13.
- Giannessi P, Martell F, Di Marsico R, . Gemcitabine in combination with capecitabine in metastatic breast carcinoma: A phase I–II study. J Clin Oncol 2005; 23Suppl:870.(Abstract)
- Sikov WM, Theall KP, Seidler R, . Gemcitabine and capecitabine in metastatic breast cancer (MBC): Brown University Oncology group (BrUOG) phase II study. J Clin Oncol 2005; 23Suppl:785.(Abstract)
- Ahn J, Kim S, Lee Y, . Phase II study of gemcitabine and capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes. J Clin Oncol 2005; 23Suppl:895.(Abstract)
- Teletaeva G, Erndiev S, Moiseyenko V. Phase II trial of Gemcitabine and Capecitabine combination in patients with metastatic breast cancer resistant to standard therapy. Ann Oncol 2003; 14Suppl 3:66.(Abstract)
- Pérez-Manga G, López-Criado P, Mendez M, . Gemcitabine (G) plus capecitabine (C) in previously treated metastatic breast cancer (MBC) patients. Final results from a phase II GOTI trial GOTI trial. Breast Cancer Res Treat 2004; 88Suppl 1:5063.(Abstract)
- Wirk B, Perez E. Role of gemcitabine in breast cancer management: An update. Semin Oncol 2006; 33:S6–S14.
- Seidman A, O´Shaughnessy J, Misset JL. Single-agent capecitabine: A reference treatment for taxane-pretreated metastatic breast cancer? Oncologist 2002; 7Suppl 6:20–8.
- Albain K, Nag S, Calderillo-Ruiz G, . gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. J Clin Oncol 2008; 263:950–7.
- O´Shaughnessy J, Miles D, Vukelja S, . Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results. J Clin Oncol 2002; 20:2812–23.
- Chan S. Gemcitabine plus Docetaxel versus capecitabine plus docetaxel for patients with anthracycline-pretreated metastatic breast cancer: A review of results of a European Phase III trial. EJC 2005;(Suppl 3):17–21.
- Fleming TR. One-sample multiple testing procedure for phase II clinical trials. Biometrics 1982;38:143–51.